PCM4EU - Personalised Cancer Medicine for all EU citizens

PCM4EU – Precision Cancer Medicine for Europe – is a Europe’s Beating Cancer Plan project funded under the EU4Health program (grant agreement 101079984) with partners from 15 countries across Europe. PCM4EU's goal is to facilitate the implementation of molecular cancer diagnostics for precision oncology such as DRUP-like clinical trials. PCM4EU is coordinated by Hans Gelderblom at the Leiden University Medical Centre (LUMC) in the Netherlands. The project contains six work packages (WPs): WP2 is about mapping and facilitating the use of molecular cancer diagnostics and WP3 is about precision oncology and promoting and help starting more national DRUP-like clinical trials in European countries. WP4 is focusing on implementing precision oncology and standards for use in diagnostics and molecular tumour boards (MTBs) in European countries. Furthermore, WP5 is about equitable and cross-border access whereas WP6 is focusing on training of the next generation of oncologists and molecular pathologists, with a dedicated youtube channel: https://www.youtube.com/@PCM4EU PCM4EU has a dedicated patient engagement strategy to ensure systematic and consistent interaction with the European cancer patient advocacy community- with the shared goal of equitable access to molecular-based clinical trials for all European cancer patients.